Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 95-101

  Toiyama, Yuji ^a   Miki, Chikao ^a   Inoue, Yasuhiro ^a   Tanaka, Koji ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Colorectal cancer; Glasgow prognostic score; Prognosis; Stage II

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; EVALUATION; FEMALE; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MODIFIED GLASGOW PROGNOSTIC SCORE; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; SURGICAL MORTALITY;

EID: 78751639839     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.175     Document Type: Article

References (37)

1. Haller DG: An overview of adjuvant therapy for colorectal cancer. Eur JCancer 31A: 1255-1263, 1995.
2. Wein A, Hahn EG, Merkel S and Hohenberger W: Adjuvant chemotherapy for stage II colon cancer. Eur JSurg Oncol 26: 730-732, 2000.
3. Figueredo A, Charette ML, Maroun J, Brouwers MC and ZurawL: Adjuvant therapy for stage IIcolon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 22: 3395-3407, 2004.
4. Gill S, Loprinzi CL, Sargent DJ, et al: Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 22: 1797-1806, 2004.
5. Canna K, McMillan DC, McKee RF, McNicol AM, HorganPG and McArdle CS: Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer 90: 1707-1709, 2004.
6. Nozoe T, Matsumata T, Kitamura M and Sugimachi K: Significance of preoperative elevation in serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 176: 335-338, 1998.
7. McMillan DC, Canna K and McArdle CS: Systemic inflammatory response predicts survival following curative resection for colorectal cancer. Br J Surg 90: 215-219, 2003.
8. Crozier JE, McKee RF, McArdle CS, et al: The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FUchemotherapy following potentially curative resection for colorectal cancer. Br J Cancer 94: 1833-1836, 2006.
9. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, CookeTG and McArdle CS: Aprospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170: 319-322, 1995.
10. Nozoe T, Matsumata T and Sugimachi K: Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23: 263-266, 2000.
11. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al: Aprospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66: 2483-2487, 2006.
12. Miki C, Konishi N, Ojima E, Hatada T, Inoue Y and Kusunoki M: C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 49: 970-976, 2004.
13. Koike Y, Miki C, Okugawa Y, et al: Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 98: 540-544, 2008.
14. Kawano M, Hirano T, Matsuda T, et al: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988.
15. Longo WE, Virgo KS, Johnson FE, et al: Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program. Ann Surg 228: 64-70, 1998.
16. Heys SD, Walker LG, Deehan DJ and Eremin OE: Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43: 163-168, 1998.
17. Longo WE, Virgo KS, Johnson FE, et al: Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 43: 83-91, 2000.
18. Forrest LM, McMillan DC, McArdle CS, Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89: 1028-1030, 2003.
19. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K and Scott HR: Aprospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92: 1834-1836, 2005.
20. Al Murri AM, Bartlett JM, Canney PA, Doughty JC, Wilson C and McMillan DC: Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94: 227-230, 2006.
21. Crumley AB, McMillan DC, McKernan M, McDonald AC and Stuart RC: Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94: 637-641, 2006.
22. Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW and McKay CJ: Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6: 450-453, 2006.
23. Ishizuka M, Nagata H, Takagi K, Horie T and Kubota K: Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246: 1047-1051, 2007.
24. Roxburgh CS, Crozier JE, Maxwell F, et al: Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer 100: 701-706, 2009.
25. Wiggers T, Arends JW, Schutte B, Volovics L and Bosman FT: Amultivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 61: 386-395, 1988.
26. Fletcher RH: Carcinoembryonic antigen. Ann Int Med 104: 66-73, 1986.
27. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA and Tangen C: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-947, 1993.
28. Tepper JE, O'Connell MJ, Niedzwiecki D, et al: Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19: 157-163, 2001.
29. Joseph NE, Sigurdson ER, Hanlon AL, et al: Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10: 213-218, 2003.
30. Joseph NE, Sigurdson ER, Hanlon AL, et al: Colon cancer survival is associated with increasing number of lymph nodes analyzed: Asecondary survey of intergroup trial INT-0089. JClin Oncol 21: 2912-2919, 2003.
31. Swanson RS, Compton CC, Stewart AK and Bland KI: The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10: 65-71, 2003.
32. Nakazaki H: Preoperative and postoperative cytokines in patients with cancer. Cancer 70: 709-713, 1992.
33. Wakuda R, Miki C and Kusunoki M: Autoreactivity against interleukin 6 as a risk factor in elderly patients with colorectal carcinoma. Arch Surg 136: 1274-1279, 2001.
34. Kinoshita T, Ito H and Miki C: Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 85: 2526-2531, 1999.
35. Miki C, Inoue Y, Toiyama Y, et al: Deficiency in systemic interleukin-1 receptor antagonist production as an operative risk factor in malnourished elderly patients with colorectal carcinoma. Crit Care Med 33: 177-180, 2005.
36. Hatada T and Miki C: Nutritional status and postoperative cytokine reponse in colorectal cancer patients. Cytokine 12: 1331-1336, 2000.
37. Jones SA, Novick D, Horiuchi S, Yamamoto N, Szalai AJ and Fuller GM: C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J Exp Med 189: 599-604, 1999.